<DOC>
	<DOCNO>NCT02993341</DOCNO>
	<brief_summary>Mechanisms reduce exposure allogeneic blood financial clinical benefit hip fracture population . Tranexamic acid ( TXA ) inexpensive medication low complication risk . Its use hip fracture population unproven . The purpose study evaluate efficacy safety topical tranexamic acid reduction peri-operative blood loss hip fracture surgery .</brief_summary>
	<brief_title>Topical Tranexamic Acid ( TXA ) Hip Fractures</brief_title>
	<detailed_description>The result study may dramatically alter manner surgeon manage hip fracture patient Canada . The use topical TXA operatively-treated hip fracture patient potential reduce perioperative blood loss consequently reduce exposure allogeneic blood transfusion . This positively influence post-operative morbidity mortality , time substantially reduce hospital length stay overall health care cost . The propose study felt minimal risk , relatively inexpensive study .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>All following criterion must meet eligible : 1 . 18 year age old 2 . Diagnosis hip fracture ( Intracapsular , Intratrochanteric Subtrochanteric ) require surgical repair 3 . Patient/surrogate decision maker provide sign informed consent Participants include study follow criterion apply : 1 . Patient document renal failure glomerular filtration rate &lt; 30ml/min/1.73m2 2 . Documented allergy tranexamic acid 3 . Current use hormone replacement therapy 4 . Acquired disturbance colour vision 5 . Refusal blood product 6 . Preoperative use anticoagulant therapy ( Coumadin , heparin &lt; 5 day surgery , fibrinolytic disorder require intraoperative antifibrinolytic treatment ) 7 . Coagulopathy ( preoperative platelet count &lt; 150,000/mm3 , International Normalized Ratio ( INR ) &gt; 1.4 , prolong Partial Thromboplastin Time ( PTT ) &gt; 1.4x normal ) 8 . Hematuria 9 . Acute coronary syndrome within 6 week fracture 10 . Any history venous thromboembolism 11 . Any intraoperative surgical/medical/anesthetic complication i.e . : myocardial infarction neurovascular injury occur prior application tranexamic acid 12 . Pregnant lactate 13 . Any major medical psychiatric disorder opinion investigator , might prevent subject completely participate study interfere interpretation study result 14 . Unable/unwilling provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>